CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (NASDAQ:CERU), a leader in Dynamic Tumor Targeting™, today announced the appointment of Adrian Senderowicz, M.D., as Senior Vice President & Chief Medical Officer, effective as of September 4, 2015. Dr. Senderowicz will succeed Edward Garmey, M.D., who will serve as a member of Cerulean’s Medical Advisory Board.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
